Premature Birth Clinical Trial
Official title:
Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor
Preterm birth, defined as birth before 37 weeks' gestation, is a leading cause of infant death and disease. Progesterone is the single most effective intervention in the prevention of preterm birth. However, current use of this therapy is limited to certain high-risk groups including women with a history of preterm birth and women with a short cervix. This study seeks to evaluate the efficacy of this preventive therapy in another high-risk group: women with arrested preterm labor. The investigators hypothesize that administration of vaginal progesterone in women who present with preterm labor but remain undelivered 12 hours after cessation of short-term therapy to inhibit contractions will result in lower rates of preterm birth before 37 weeks' than will administration of placebo.
RESEARCH DESIGN AND METHODS
The investigators will perform a randomized, blinded, placebo-controlled trial to evaluate
the use of vaginal progesterone in women with arrested preterm labor after 24 weeks'
gestation to reduce the risk of preterm birth before 37 weeks' gestation. Women enrolled in
the study will be randomized to daily vaginal administration of progesterone (200 mg) or
placebo from time of enrollment until 36 6/7 weeks' gestation. Women will be eligible if they
have a singleton or twin gestation between 24 0/7 and 33 6/7 weeks' gestation and initially
present with regular uterine contractions and a clinical diagnosis of preterm labor but
remain undelivered without further cervical change 12 hours after discontinuation of acute
tocolytic therapy. Women may also participate if it has been less than if they are considered
eligible for discharge based on attending physician judgement prior to the 12 hour period of
time.
Randomization and Blinding- Participants in the study will be randomized using a
computer-generated randomization scheme with 1:1 allocation to receive progesterone or
placebo. Investigators and research team members, participants, and the obstetric providers
will be blinded to the allocated intervention.
Procedures-
- Data collection- Information will be recorded from the participant's medical record.
Additional study information not included in the medical record will be obtained
directly from the participant in an interview with the research team member.
- Follow-up- Regardless of whether the participant remains hospitalized or is discharged
prior to delivery, she will meet with a study coordinator every 2 weeks. During the
follow-up visit, a study team member will discuss compliance with the study drug and
possible side effects. The participant will fill out a 1-page questionnaire that asks
questions about compliance and side effects. This information will be recorded and
provided to the Data Safety and Monitoring Board at the midpoint review.
SAMPLE SIZE ESTIMATION
The investigators plan to enroll 120 patients, with a 1:1 allocation to treatment and
placebo. This sample size is adequate to detect a one-half reduction in the primary outcome,
delivery before 37 weeks.
STATISTICAL ANALYSIS
Baseline characteristics of women randomized to progesterone will be compared with women
randomized to placebo. Rates of delivery before 37 weeks' gestation will be compared among
the groups using the Chi-square test. Secondary outcomes will be evaluated using the
Chi-square test for binary outcomes and the Student t-test for continuous outcomes. Length of
time from enrollment to delivery will be analyzed using Kaplan-Meier curves and the Cox
proportional hazards model. All analyses will be performed using the intention-to-treat
principle.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05048550 -
Babies in Glasses; a Feasibility Study.
|
N/A | |
Active, not recruiting |
NCT03655639 -
Local Version of the Multi-center PREVENT Study Evaluating Cardio-respiratory Instability in Premature Infants
|
||
Enrolling by invitation |
NCT05542108 -
Adding Motion to Contact: A New Model for Low-cost Family Centered Very-early Onset Intervention in Very Preterm-born Infants
|
N/A | |
Completed |
NCT03680157 -
Comparing Rater Reliability of Familiar Practitioners to Blinded Coders
|
||
Completed |
NCT03337659 -
A Cluster Randomized Controlled Trial of FICare at 18 Months
|
N/A | |
Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
Completed |
NCT03251729 -
Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix
|
Phase 4 | |
Not yet recruiting |
NCT05039918 -
Neonatal Experience of Social Touch
|
N/A | |
Not yet recruiting |
NCT03418012 -
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
|
N/A | |
Not yet recruiting |
NCT03418311 -
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome
|
N/A | |
Completed |
NCT02913495 -
Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
|
Phase 4 | |
Not yet recruiting |
NCT02880696 -
Perception of Temporal Regularity in Tactile Stimulation: a Diffuse Correlation Spectroscopy Study in Preterm Neonates
|
N/A | |
Completed |
NCT02952950 -
Is it Possible to Prolong the Duration of Breastfeeding in Premature Infants? a Prospectivt Study
|
N/A | |
Completed |
NCT02661360 -
Effects of Swaddling on Infants During Feeding
|
N/A | |
Completed |
NCT02879799 -
Family Integrated Care (FICare) in Level II NICUs
|
N/A | |
Completed |
NCT02743572 -
Iron-fortified Parenteral Nutrition in the Prevention and Treatment of Anemia in Premature Infants
|
N/A | |
Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
Completed |
NCT01163188 -
Social Adjustment and Quality of Life After Very Preterm Birth
|
N/A | |
Terminated |
NCT00675753 -
Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families
|
N/A | |
Completed |
NCT00271115 -
Kangaroo Holding and Maternal Stress
|
N/A |